COMP <GO>
ASTE vs TMO // REVENUE GROWTH (YOY)
Astec Industries Inc. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: ASTE 5
— TMO 7
▲ REVENUE GROWTH (YOY) LEADER: ASTE
LAST: $39.27 (-1.60%) • MKT CAP: $918.9M
revenue-growth
8.10%
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
revenue-growth
3.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ASTE VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ASTE | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 26.50% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 5.60% | 9.30% | -3.70 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 11.6x | 30.4x | -18.80 | ASTE | /valuation <GO> |
| Free Cash Flow Yield | 2.25% | 2.40% | -0.15 | TMO | /fcf-yield <GO> |
| Operating Margin | 4.70% | 17.40% | -12.70 | TMO | /operating-margins <GO> |
| Net Profit Margin | 2.80% | 15.10% | -12.30 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 8.10% | 3.90% | +4.20 | ASTE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.29% | 0.24% | +1.05 | ASTE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.01 | 4.50 | -1.49 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | ASTE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 50.5 | 62.9 | -12.40 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 22.0x | 36.3x | -14.30 | ASTE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $918.9M | $262.22B | -$261.30B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ASTE REV | TMO REV | ASTE GROSS % | TMO GROSS % | ASTE FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.41B | $44.56B | 26.5% | — | $20.7M | $6.29B |
| FY 2024 | $1.31B | $42.88B | 25.1% | — | $2.5M | $7.27B |
| FY 2023 | $1.34B | $42.86B | — | — | $27.8M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ASTE // BETA —
TMO // BETA 0.94